Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) PPM1D Antibodies:
anti-Human PPM1D Antibodies:
anti-Rat (Rattus) PPM1D Antibodies:
Go to our pre-filtered search.
Human Polyclonal PPM1D Primary Antibody for WB - ABIN392853
Song, Han, Sabapathy, Lee, Yu, Choi: Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation. in The Journal of biological chemistry 2010
Show all 7 Pubmed References
Human Polyclonal PPM1D Primary Antibody for IP, WB - ABIN151547
Lee, Lee, Moon, Shim, Fornace, Cha: Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1-mediated downregulation of intrinsic stress signaling pathways. in Stem cells (Dayton, Ohio) 2009
Show all 4 Pubmed References
Human Polyclonal PPM1D Primary Antibody for IF (p), IHC (p) - ABIN740415
Wang, Cui, Wen, Guo, Zhang, Chen: Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway. in Oncology letters 2017
The results suggest that Wip1 could protect the heart from MI-induced ischemic injury.
These data collectively indicate that Wip1 modulates host sensitivity to colitis by intrinsically regulating immune cells.
Wip1 phosphatase plays a vital role in regulating hippocampal synaptic plasticity by modulating the phosphorylation of CaMKII (show CAMK2G Antibodies).
Findings indicate that the PPM1D-Ulk1 (show ULK1 Antibodies) axis plays a pivotal role in genotoxic stress-induced autophagy.
This suggests an important cross-talk between SHH and WIP1 pathways that accelerates tumorigenesis and supports WIP1 inhibition as a potential treatment strategy for MB.
WIP1 phosphatase plays a pro-adipogenic role by interacting directly with PPARgamma (show PPARG Antibodies) and dephosphorylating p-PPARgamma (show PPARG Antibodies) S112 in vitro and in vivo.
this study shows that knock out of Wip1 in mouse aggravates colonic inflammation and increases neutrophils migration
the data indicate that the WIP1 phosphatase functions to maintain insulin (show INS Antibodies) sensitivity and glucose homeostasis.
Study suggests a potential protective function of p53 (show TP53 Antibodies)-induced phosphatase 1 in mood stabilization.
loss of Wip1 phosphatase induces a p53 (show TP53 Antibodies)-dependent, but p21 (show D4S234E Antibodies)-independent, mechanism that impairs B-cell development by enhancing apoptosis in early B-cell precursors
These data support the notion that Wip1 contributes to the formation of the ERMs in PDR membranes via NF-kappaB (show NFKB1 Antibodies) signaling.
In an in vitro model of the blood-brain barrier, LPS (show IRF6 Antibodies) raised Wip1 expression. Wip1 knockdown increased permeability and decreased transepithelial electrical resistance, protein expression of ZO-1 (show TJP1 Antibodies), and occluding. Wip1 silencing augmented TNF-alpha (show TNF Antibodies), IL-1beta (show IL1B Antibodies), IL-12 (show IL12A Antibodies), and IL-6 (show IL6 Antibodies). Sonic hedgehog (show SHH Antibodies) signaling was activated by Wip1 overexpression and inhibited by silencing. Wip1 may protect the BBB (show ALMS1 Antibodies) against LPS (show IRF6 Antibodies) damage via SHH (show SHH Antibodies) signal...
Studies suugest Wip1 role in tumorigenesis through regulation of p53 (show TP53 Antibodies) and p38MAPK (show MAPK14 Antibodies) pathways.
The inhibition of Wip1 might fortify p53 (show TP53 Antibodies)-mediated tumor suppression by Mdm2 (show MDM2 Antibodies) antagonists.
Wip1 suppressed ovarian cancer cell invasion, migration, epithelial to mesenchymal transition (EMT (show ITK Antibodies)), and ovarian cancer metastasis in xenograft animal models.
model reproduces the observed cellular phenotypes in experiments: oscillatory (for low DNA damage) regulated by negative feedback loops involving mainly p53 (show TP53 Antibodies) and Mdm2 (show MDM2 Antibodies) and apoptotic or senescent (for high DNA damage) regulated by the positive p53 (show TP53 Antibodies)/Wip1/miR-16 (show GDE1 Antibodies) feedback loop
Wip1 activity and its relevance to cancer as an oncoprotein is reviewed
The authors show that a global spread of ATM (show ATM Antibodies) activity on chromatin and phosphorylation of ATM (show ATM Antibodies) targets including KAP1 (show CDKN3 Antibodies) control Plk1 (show PLK1 Antibodies) re-activation. These phosphorylations are rapidly counteracted by the chromatin-bound phosphatase Wip1, allowing cell cycle restart despite persistent ATM (show ATM Antibodies) activity present at DNA lesions.
Truncating and missense PPM1D mutations are associated with prostate cancer.
The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. The expression of this gene is induced in a p53-dependent manner in response to various environmental stresses. While being induced by tumor suppressor protein TP53/p53, this phosphatase negatively regulates the activity of p38 MAP kinase, MAPK/p38, through which it reduces the phosphorylation of p53, and in turn suppresses p53-mediated transcription and apoptosis. This phosphatase thus mediates a feedback regulation of p38-p53 signaling that contributes to growth inhibition and the suppression of stress induced apoptosis. This gene is located in a chromosomal region known to be amplified in breast cancer. The amplification of this gene has been detected in both breast cancer cell line and primary breast tumors, which suggests a role of this gene in cancer development.
, p53-induced protein phosphatase 1
, protein phosphatase 1D
, protein phosphatase 2C isoform delta
, protein phosphatase magnesium-dependent 1 delta
, protein phosphatase 1D magnesium-dependent, delta isoform
, protein phosphatase 2C delta isoform
, protein phosphatase Wip1
, wild-type p53-induced phosphatase 1